Eitan M. Kohan

Eitan M. Kohan

Auto-generated profile, based on publicly available information

Eitan M. Kohan

Department of Orthopaedic Surgery, Hackensack University Medical Center, Hackensack, NJ, USA

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2017 in Journal of Shoulder and Elbow Surgery
Verified
Journal Article
Closed access
EKEitan M. Kohan
Eitan M. Kohan
PCPeter N. Chalmers
Peter N. Chalmers
DSDane Salazar
Dane Salazar
JKJay D. Keener
Jay D. Keener
KYKen Yamaguchi
Ken Yamaguchi
ACAaron M. Chamberlain
Aaron M. Chamberlain

1 February 2019 in Journal of Shoulder and Elbow Surgery
Verified
Journal Article
Closed access
EKEitan M. Kohan
Eitan M. Kohan
JHJ. Ryan Hill
J. Ryan Hill
MSMaria Schwabe
Maria Schwabe
AAAlexander W. Aleem
Alexander W. Aleem
JKJay D. Keener
Jay D. Keener
ACAaron M. Chamberlain
Aaron M. Chamberlain

19 January 2022 in Journal of Shoulder and Elbow Surgery
Verified
Journal Article
Closed access
EKEitan M. Kohan
Eitan M. Kohan
BHBenjamin A. Hendy
Benjamin A. Hendy
LKLuke L. Kowal
Luke L. Kowal
JKJacob Kirsch
Jacob Kirsch
PGPietro Gregori
Pietro Gregori
SNSurena Namdari
Surena Namdari

1 January 2015 in International Journal of Spine Surgery
Verified
Journal Article
Open access
PDF file
KVKushagra Verma
Kushagra Verma
EKEitan Kohan
Eitan Kohan
CAChristopher P. Ames
Christopher P. Ames
DCDana L. Cruz
Dana L. Cruz
VDVedat Deviren
Vedat Deviren
TEThomas J. Errico
Thomas J. Errico
Background Multilevel spinal fusions have typically been associated with significant blood loss. Previous studies have shown a reduction in blood loss with antifibrinolytics in both adolescent and adult spinal deformity patients. While this has been mirrored in other subspecialties as well, the dosing of TXA remains highly variable. To date, there remains a paucity of data guiding dosing for TXA in spine surgery and orthopedic surgery as a whole. Methods/Design One hundred and fifty patients from 3 institutions (50 each site) will be consecutively enrolled and randomized to either a high dose of TXA (50mg/kg loading followed by 20mg/kg hourly) or a lose dose (10mg/kg, then 1mg/kg hourly). Both surgeons and patients will be blinded to the treatment group. Primary outcomes will be perioperative blood loss, drain output, and transfusion rate. Secondary outcomes will be length of stay, complications, and overall cost. Discussion The primary goal of this study is to provide level-1 comparative data for two TXA dosing regimens in adult spinal deformity surgery. Management of blood loss remains a critical factor in reducing complications during spinal deformity surgery. The null hypothesis is that there is no difference between high- and low-dose TXA with respect to any of the primary or secondary outcomes.

1 May 2020 in Seminars in Arthroplasty: JSES
Verified
Journal Article
Closed access
EKEitan M. Kohan
Eitan M. Kohan
OROrthopaedic Resident
Orthopaedic Resident
AAAlexander W. Aleem
Alexander W. Aleem
ACAaron M. Chamberlain
Aaron M. Chamberlain
JKJay D. Keener
Jay D. Keener

14 October 2022 in Journal of Shoulder and Elbow Surgery
Verified
Journal Article
Closed access
MMMartinus Megalla
Martinus Megalla
NINareena Imam
Nareena Imam
LBLainey Bukowiec
Lainey Bukowiec
DCDaniel Coban
Daniel Coban
MMMartin Malik
Martin Malik
FAFrank G. Alberta
Frank G. Alberta